Federico De Marchi

Putting the I in AML: Artificial Intelligence and Machine Learning in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) produces more molecular, imaging, and clinical data per patient than any hematologist can hold in mind at once, and each revision of the WHO, ICC, and European LeukemiaNet (ELN) frameworks adds to the load. Artificial intelligence (AI) and machine lea...